[The value and drawbacks of evaluation of the risk of fetal trisomy 21].
Taieb
J
J
Service de Biochimie et d'Hormonologie, Hôpital Antoine-Béclère, Clamart.
Benattar
C
C
Audibert
F
F
Frydman
R
R
Lindenbaum
A
A
D015415:Biomarkers / Q000032:analysis; D004314:Down Syndrome / Q000175:diagnosis* / Q000523:psychology; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000523:psychology; D005326:Fetal Proteins / Q000032:analysis; D006801:Humans; D007603:Jurisprudence; D008423:Maternal Age; D011247:Pregnancy / Q000523:psychology; D011257:Pregnancy Proteins / Q000032:analysis; D011296:Prenatal Diagnosis / Q000523:psychology; D012307:Risk Factors; D016216:Ultrasonography, Prenatal
D015415:Biomarkers; D005326:Fetal Proteins; D011257:Pregnancy Proteins